Product Images Methylphenidate Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Methylphenidate Hydrochloride NDC 43598-438 by Dr.reddys Laboratories Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

container1 - Container1

container1 - Container1

This appears to be a label of medication called "Methylphenidate Hydrochloride Extended-Release Tablets" with information including the quantity of 100 tablets and dosage of 18mg. The label also includes a reference to "Dr. Roddys" and two sets of alphanumeric code (one possibly a location) "NG 45595 43801" and "ShpuaioiouB 3 36105 B o". Without further context, the purpose or efficacy of this medication or the significance of the codes cannot be determined.*

container2 - container2

container2 - container2

This text is a label of a medicine bottle. The medicine is Methylphenidate Hydrochloride Extended-Release Tablets, with a strength of 27 mg. The bottle contains 100 tablets and was likely filled by a pharmacy called Dr. Roddys.*

container3 - container3

container3 - container3

This is a medication label for Methylphenidate Hydrochloride Extended-Release Tablets at a strength of 36 mg.*

container4 - container4

container4 - container4

The text indicates the details of a medication called Methylphenidate Hydrochloride Extended-Release Tablets, which come in a 54 mg dosage. The manufacturer of the tablets is mentioned as "DrRoddys", but no further information is provided.*

figure1 - figure1

figure1 - figure1

figure2 - figure2

figure2 - figure2

The text describes a study using extended-release tablets of Methylphenidate Hydrochloride to treat symptoms of inattention and overactivity in individuals. The dosage was a maximum of 15 7| BN tablets once daily, compared to a placebo. The study included three weeks, and the efficacy was measured using the Inattention/Overactivity Scale. The results showed a significant reduction in symptoms in the Methylphenidate Hydrochloride group compared to the placebo group in all three weeks of the study.*

figure3 - figure3

figure3 - figure3

This appears to be a table or chart showing the results of a study involving a drug called Attentive 2.0, specifically comparing the effects of the drug to a placebo. The drug in question is Methylphenidate Hydrochloride Extended-Release Tablets, which is taken once a day. The chart appears to show the results of testing the drug and the placebo over a period of time after the initial dose. However, there is not enough information to fully understand the study or draw any conclusions from it.*

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.